What is the recommended duration of Tirzepatide treatment for weight loss?

 Tirzepatide is a medication that is FDA-approved for the treatment of type 2 diabetes. It works as a dual GLP-1 agonist and GIP agonist to maximize similar benefits that are seen with GLP-1 medications such as semaglutide

1

. During clinical trials, participants lost up to 20.9% of their starting weight with 15-mg doses of tirzepatide

1

.The recommended duration of tirzepatide treatment for weight loss may vary depending on the individual, their starting weight, and other factors. According to a study published on NCBI, clinicians are likely to follow up with patients in set intervals as early as four weeks or as late as 12 weeks, depending on the dosage and the local standard of care for diabetes management

2

.In a systematic review and meta-analysis of all currently available randomized controlled trials (RCTs) of tirzepatide in individuals with T2DM and obesity, a significant reduction in body weight in the tirzepatide group versus the placebo group by -9.81 kg was observed

3

. The study duration varied from 12 to 72 weeks, depending on the trial

3

.It is important to note that the weight loss results may vary depending on the individual, their starting weight, and other factors. If you are considering tirzepatide for weight loss, it is important to discuss the potential benefits and risks with your healthcare provider, including the recommended duration of treatment.

1

nejm

2

nih

3

nih